Abiopharma

News list

📋 MARK A GOLDSMITH (Director) plans to sell 80K shares of Revolution Medicines, Inc. (at $211.74 each, total $16.9M) Filed: Aug 21, 2026 | ID: 008543

Full text

News bot Aug. 21, 2026, 8:38 p.m.
📋 Form 144 Filing: MARK A GOLDSMITH

Company: Revolution Medicines, Inc.

Filing Date: 2026-08-21

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 80,000
- Price per Share: $211.74
- Total Value: $16,938,800.00
- Planned Sale Date: 2026-08-21
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39219
- Issuer Contact Phone: 6504816801
- Issuer Address: 700 Saginaw Drive, Redwood City, CA, 94063
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 214336418.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Mark A Goldsmith